{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:39:18Z","timestamp":1684863558920},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/bf02685894","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T14:17:41Z","timestamp":1187273861000},"page":"113-133","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Initiation of primary anti-vaccinia virus immunity in vivo"],"prefix":"10.1007","volume":"37","author":[{"given":"Matthew A.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Norbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02685894_CR1","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","volume":"286","author":"E Marshall","year":"1999","unstructured":"Marshall E: Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244\u20132245.","journal-title":"Science"},{"key":"BF02685894_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00006454-199902000-00002","volume":"18","author":"M Radetsky","year":"1999","unstructured":"Radetsky M: Smallpox: a history of its rise and fall. Pediatr Infect Dis J 1999; 18:85\u201393.","journal-title":"Pediatr Infect Dis J"},{"key":"BF02685894_CR3","first-page":"158","volume":"20","author":"AW Downie","year":"1939","unstructured":"Downie AW: Immunological relationship of the virus of spontaneous cowpox to vaccinia virus. J Exp Pathol 1939; 20: 158\u2013176.","journal-title":"J Exp Pathol"},{"key":"BF02685894_CR4","unstructured":"Centers for Disease Control and Prevention: Human Monkeypox\u2014Kasai Oriental, Demoncratic Republic of Congo, Feburary 1996\u2013October 1997. MMWR Morb Mortal Wkly 1997; 46:1168\u20131171."},{"key":"BF02685894_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"350","author":"KD Reed","year":"2004","unstructured":"Reed KD, Melski JW, Graham MB, et al: The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004; 350:342\u2013350.","journal-title":"N Engl J Med"},{"key":"BF02685894_CR6","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","volume":"289","author":"JS Halsell","year":"2003","unstructured":"Halsell JS, Riddle JR, Atwood JE, et al: Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003; 289:3283\u20133289.","journal-title":"JAMA"},{"key":"BF02685894_CR7","first-page":"397","volume":"15","author":"F Fenner","year":"1993","unstructured":"Fenner F: Smallpox: emergence, global spread, and eradication. Hist Philos Life Sci 1993; 15:397\u2013420.","journal-title":"Hist Philos Life Sci"},{"key":"BF02685894_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","volume":"281","author":"JM Lane","year":"1969","unstructured":"Lane JM, Ruben FL, Neff JM, Millar JD: Complications of smallpox vaccination, 1968. N Engl J Med 1969; 281:1201\u20131208.","journal-title":"N Engl J Med"},{"key":"BF02685894_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nm1261","volume":"11","author":"Y Edghill-Smith","year":"2005","unstructured":"Edghill-Smith Y, Golding H, Manischewitz J, et al: Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med 2005; 11:740\u2013747.","journal-title":"Nat Med"},{"key":"BF02685894_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","volume":"428","author":"PL Earl","year":"2004","unstructured":"Earl PL, Americo JL, Wyatt LS, et al: Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004; 428:182\u2013185.","journal-title":"Nature"},{"key":"BF02685894_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1006\/viro.1995.1208","volume":"208","author":"K Mossman","year":"1995","unstructured":"Mossman K, \u00dcpton C, Buller RM, McFadden G: Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 1995; 208:762\u2013769.","journal-title":"Virology"},{"key":"BF02685894_CR12","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/jvi.69.8.4633-4639.1995","volume":"69","author":"A Alcami","year":"1995","unstructured":"Alcami A, Smith GL: Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 1995; 69:4633\u20134639.","journal-title":"J Virol"},{"key":"BF02685894_CR13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1099\/0022-1317-83-8-1953","volume":"83","author":"JA Symons","year":"2002","unstructured":"Symons JA, Tscharke DC, Price N, Smith GL: A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol 2002; 83:1953\u20131964.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR14","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1099\/0022-1317-80-10-2751","volume":"80","author":"DC Tscharke","year":"1999","unstructured":"Tscharke DC, Smith GL: A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 1999; 80 (Pt 10):2751\u20132755.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR15","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1099\/0022-1317-83-8-1977","volume":"83","author":"DC Tscharke","year":"2002","unstructured":"Tscharke DC, Reading PC, Smith GL: Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 2002; 83:1977\u20131986.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1084\/jem.20041912","volume":"201","author":"DC Tscharke","year":"2005","unstructured":"Tscharke DC, Karupiah G, Zhou J, et al: Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 2005; 201:95\u2013104.","journal-title":"J Exp Med"},{"key":"BF02685894_CR17","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1099\/vir.0.19285-0","volume":"84","author":"PC Reading","year":"2003","unstructured":"Reading PC, Smith GL: A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 2003; 84:1973\u20131983.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1099\/vir.0.81556-0","volume":"87","author":"N Jacobs","year":"2006","unstructured":"Jacobs N, Chen RA, Gubser C, Najarro P, Smith GL: Intradermal immune response after infection with vaccinia virus. J Gen Virol 2006; 87:1157\u20131161.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR19","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1084\/jem.158.5.1522","volume":"158","author":"DA Hume","year":"1983","unstructured":"Hume DA, Robinson AP, MacPherson GG, Gordon S: The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4\/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med 1983; 158:1522\u20131536.","journal-title":"J Exp Med"},{"key":"BF02685894_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ni1307","volume":"7","author":"F Ginhoux","year":"2006","unstructured":"Ginhoux F, Tacke F, Angeli V, et al: Langerhans cells arise from monocytes in vivo. Nat Immunol 2006; 7:265\u2013273.","journal-title":"Nat Immunol"},{"key":"BF02685894_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4049\/jimmunol.81.6.460","volume":"81","author":"M Nishmi","year":"1958","unstructured":"Nishmi M, Bernkopf H: The toxic effect of vaccinia virus on leucocytes in vitro. J Immunol 1958; 81:460\u2013466.","journal-title":"J Immunol"},{"key":"BF02685894_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0042-6822(85)90138-2","volume":"147","author":"RJ Natuk","year":"1985","unstructured":"Natuk RJ, Holowczak JA: Vaccinia virus proteins on the plasma membrane of infected cells. III. Infection of pentoneal macrophages. Virology 1985; 147:354\u2013372.","journal-title":"Virology"},{"key":"BF02685894_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0378-1119(94)90257-7","volume":"142","author":"CC Broder","year":"1994","unstructured":"Broder CC, Kennedy PE, Michaels F, Berger EA: Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 1994; 142:167\u2013174.","journal-title":"Gene"},{"key":"BF02685894_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.67.6.883","volume":"67","author":"JW Beard","year":"1938","unstructured":"Beard JW, Rous PJ: The fate of vaccinia virus on cultivation in vitro with Kupffer cells (RE cells). J Exp Med 1938; 67:883\u2013910.","journal-title":"J Exp Med"},{"key":"BF02685894_CR25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/iai.2.6.783-790.1970","volume":"2","author":"WA Tompkins","year":"1970","unstructured":"Tompkins WA, Zarling JM, Rawls WE: In vitro assessment of cellular immunity to vaccinia virus: contribution of lymphocytes and macrophages. Infect Immun 1970; 2:783\u2013790.","journal-title":"Infect Immun"},{"key":"BF02685894_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/iai.6.1.9-16.1972","volume":"6","author":"FR Avila","year":"1972","unstructured":"Avila FR, Schultz RM, Tompkins WA: Specific macrophage immunity to vaccinia virus: macrophagevirus interaction. Infect Immun 1972; 6:9\u201316.","journal-title":"Infect Immun"},{"key":"BF02685894_CR27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1128\/iai.14.4.1014-1021.1976","volume":"14","author":"C McLaren","year":"1976","unstructured":"McLaren C, Cheng H, Spicer DL, Tompkins WA: Lymphocyte and macrophage responses after vaccinia virus infections. Infect Immun 1976; 14:1014\u20131021.","journal-title":"Infect Immun"},{"key":"BF02685894_CR28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/iai.9.2.452-459.1974","volume":"9","author":"B Greer","year":"1974","unstructured":"Greer B, Delfs D, McElree H: Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits. Infect Immun 1974; 9:452\u2013459.","journal-title":"Infect Immun"},{"key":"BF02685894_CR29","first-page":"41","volume":"17","author":"S Ueda","year":"1973","unstructured":"Ueda S, Nozima T: Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection. Acta Virol 1973; 17:41\u201349.","journal-title":"Acta Virol"},{"key":"BF02685894_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF01317432","volume":"48","author":"U Koszinowski","year":"1975","unstructured":"Koszinowski U, Kruse F, Thomssen R: Interactions between vaccinia virus and sensitized macrophages in vitro. Arch Virol 1975; 48:335\u2013345.","journal-title":"Arch Virol"},{"key":"BF02685894_CR31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/iai.26.1.328-338.1979","volume":"26","author":"NA Buchmeier","year":"1979","unstructured":"Buchmeier NA, Gee SR, Murphy FA, Rawls WE: Abortive replication of vaccinia virus in activated rabbit macrophages. Infect Immun 1979; 26:328\u2013338.","journal-title":"Infect Immun"},{"key":"BF02685894_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/0042-6822(91)90575-V","volume":"185","author":"JR Rodriguez","year":"1991","unstructured":"Rodriguez JR, Rodriguez D, Esteban M: Interferon treatment inhibits early events in vaccinia virus gene expression in infected mice. Virology 1991; 185:929\u2013933.","journal-title":"Virology"},{"key":"BF02685894_CR33","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1126\/science.7690156","volume":"261","author":"G Karupiah","year":"1993","unstructured":"Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993; 261:1445\u20131448.","journal-title":"Science"},{"key":"BF02685894_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1006\/viro.1994.1087","volume":"198","author":"Z Melkova","year":"1994","unstructured":"Melkova Z, Esteban M: Interferon-gamma severly inhibits DNA synthesis of vaccinia virus in a macrophage cell line. Virology 1994; 198:731\u2013735.","journal-title":"Virology"},{"key":"BF02685894_CR35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/jvi.69.2.910-915.1995","volume":"69","author":"N Harris","year":"1995","unstructured":"Harris N, Buller RM, Karupiah G: Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 1995; 69:910\u2013915.","journal-title":"J Virol"},{"key":"BF02685894_CR36","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.181.6.2171","volume":"181","author":"G. Karupiah","year":"1995","unstructured":"Karupiah G., Harris N: Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med 1995; 181:2171\u20132179.","journal-title":"J Exp Med"},{"key":"BF02685894_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","volume":"174","author":"N van Rooijen","year":"1994","unstructured":"van Rooijen N, Sanders A: Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174:83\u201393.","journal-title":"J Immunol Methods"},{"key":"BF02685894_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.194.8.1171","volume":"194","author":"H Nakano","year":"2001","unstructured":"Nakano H, Yanagita M, Gunn MD: CD11c(+)B220(+) Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001; 194:1171\u20131178.","journal-title":"J Exp Med"},{"key":"BF02685894_CR39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/156.4.597","volume":"156","author":"BC West","year":"1987","unstructured":"West BC, Eschete ML, Cox ME, King JW: Neutrophil uptake of vaccinia virus in vitro. J Infect Dis 1987; 156:597\u2013606.","journal-title":"J Infect Dis"},{"key":"BF02685894_CR40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1203\/00006450-198207000-00005","volume":"16","author":"JF Jones","year":"1982","unstructured":"Jones JF: Interactions between human neutrophils and vaccinia virus: induction of oxidative metabolism and virus inactivation. Pediatr Res 1982; 16:525\u2013529.","journal-title":"Pediatr Res"},{"key":"BF02685894_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","volume":"344","author":"B Moss","year":"2006","unstructured":"Moss B: Poxvirus entry and membrane fusion. Virology 2006; 344:48\u201354.","journal-title":"Virology"},{"key":"BF02685894_CR42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.138.3.877","volume":"138","author":"RJ Natuk","year":"1987","unstructured":"Natuk RJ, Welsh RM: Accumulation and chemotaxis of natural killer\/large granular lymphocytes at sites of virus replication. J Immunol 1987; 138:877\u2013883.","journal-title":"J Immunol"},{"key":"BF02685894_CR43","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.4049\/jimmunol.175.4.2152","volume":"175","author":"M Prlic","year":"2005","unstructured":"Prlic M, Gibbs J, Jameson SC: Characteristics of NK cell migration early after vaccinia infection. J Immunol 2005; 175:2152\u20132157.","journal-title":"J Immunol"},{"key":"BF02685894_CR44","unstructured":"Brutkiewicz RR, Klaus SJ, Welsh RM: Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 antigen expression. 1992; 11:203\u2013214."},{"key":"BF02685894_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.it.2005.02.007","volume":"26","author":"C Bottino","year":"2005","unstructured":"Bottino C, Castriconi R, Moretta L, Moretta A: Cellular ligands of activating NK receptors. Trends Immunol 2005; 26:221\u2013226.","journal-title":"Trends Immunol"},{"key":"BF02685894_CR46","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1128\/JVI.80.5.2225-2233.2006","volume":"80","author":"SE Chisholm","year":"2006","unstructured":"Chisholm SE, Reyburn HT: Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol 2006; 80:2225\u20132233.","journal-title":"J Virol"},{"key":"BF02685894_CR47","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.4049\/jimmunol.153.11.5133","volume":"153","author":"JF Bukowski","year":"1994","unstructured":"Bukowski JF, Morita CT, Brenner MB: Recognition and destruction of virus-infected cells by human gamma-delta CTL. J Immunol 1994; 153:5133\u20135140.","journal-title":"J Immunol"},{"key":"BF02685894_CR48","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy MK, Glaccum M, Brown SN, et al: Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191:771\u2013780.","journal-title":"J Exp Med"},{"key":"BF02685894_CR49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1084\/jem.20021847","volume":"197","author":"M Prlic","year":"2003","unstructured":"Prlic M, Blazar BR, Farrar MA, Jameson SC: In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 2003; 197:967\u2013976.","journal-title":"J Exp Med"},{"key":"BF02685894_CR50","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.136.12.4674","volume":"136","author":"L Stitz","year":"1986","unstructured":"Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM: Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J Immunol 1986; 136:4674\u20134680.","journal-title":"J Immunol"},{"key":"BF02685894_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-065X.1997.tb01008.x","volume":"159","author":"RM Welsh","year":"1997","unstructured":"Welsh RM, Lin MY, Lohman BL, Varga SM, Zarozinski CC, Selin LK: Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections. Immunol Rev 1997; 159:79\u201393.","journal-title":"Immunol Rev"},{"key":"BF02685894_CR52","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.4049\/jimmunol.166.11.6784","volume":"166","author":"LK Selin","year":"2001","unstructured":"Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsud\u00e1 E, Welsh RM: Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 2001; 166:6784\u20136794.","journal-title":"J Immunol"},{"key":"BF02685894_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1084\/jem.115.3.503","volume":"115","author":"LA Glasgow","year":"1962","unstructured":"Glasgow LA, Habel K: The role of interferon in vaccinia virus infection of mouse embryo tissue culture. J Exp Med 1962; 115:503\u2013512.","journal-title":"J Exp Med"},{"key":"BF02685894_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature01783","volume":"424","author":"SS Diebold","year":"2003","unstructured":"Diebold SS, Montoya M, Unger H, et al: Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003; 424:324\u2013328.","journal-title":"Nature"},{"key":"BF02685894_CR55","doi-asserted-by":"publisher","first-page":"15974","DOI":"10.1074\/jbc.270.27.15974","volume":"270","author":"OR Colamonici","year":"1995","unstructured":"Colamonici OR, Domanski P, Swieitzer SM, Larner A, Buller RM: Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 1995; 270:15974\u201315978.","journal-title":"J Biol Chem"},{"key":"BF02685894_CR56","doi-asserted-by":"crossref","unstructured":"Symons JA, Alcami A, Smith GL: Vaccinia virus encodes a soluble type 1 interferon receptor of novel structure and broad species specificity. 1995; 81:551\u2013560.","DOI":"10.1016\/0092-8674(95)90076-4"},{"key":"BF02685894_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/viro.1997.8527","volume":"232","author":"H Liptakova","year":"1997","unstructured":"Liptakova H, Kontsekova E, Alcami A, Smith GL, Kontsek P: Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alphal and IFN-alpha2. Virology 1997; 232:86\u201390.","journal-title":"Virology"},{"key":"BF02685894_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00090.x","volume":"148","author":"MF van den Broek","year":"1995","unstructured":"van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M: Immune defence in mice lacking type I and\/or type II interferon receptors. Immunol Rev 1995; 148:5\u201318.","journal-title":"Immunol Rev"},{"key":"BF02685894_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/eji.1830200123","volume":"20","author":"MR Kohonen-Corish","year":"2007","unstructured":"Kohonen-Corish MR, King NJ, Woodhams CE, Ramshaw, IA: Immunodeficient mice recover from infection with vaccinia virus expressing interferongamma. Eur J Immunol 1990; 20:157\u2013161.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR60","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1126\/science.8456301","volume":"259","author":"S Huang","year":"1993","unstructured":"Huang S, Hendriks W, Althage A, et al: Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259:1742\u20131745.","journal-title":"Science"},{"key":"BF02685894_CR61","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1099\/vir.0.80904-0","volume":"86","author":"NW Bartlett","year":"2005","unstructured":"Bartlett NW, Buttigieg K, Kotenko SV, Smith GL: Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 2005; 86:1589\u20131596.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR62","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","volume":"172","author":"R Xu","year":"2004","unstructured":"Xu R, Johnson AJ, Liggitt D, Bevan MJ: Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 2004; 172:6265\u20136271.","journal-title":"J Immunol"},{"key":"BF02685894_CR63","doi-asserted-by":"publisher","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","volume":"79","author":"DH Davies","year":"2005","unstructured":"Davies DH, McCausland MM, Valdez C, et al: Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 2005; 79:11724\u201311733.","journal-title":"J Virol"},{"key":"BF02685894_CR64","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1099\/vir.0.80660-0","volume":"86","author":"M Law","year":"2005","unstructured":"Law M, Putz MM, Smith GL: An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol 2005; 86:991\u20131000.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR65","doi-asserted-by":"publisher","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","volume":"79","author":"S Lustig","year":"2005","unstructured":"Lustig S, Fogg C, Whitbeck JC, Eisenberg RJ, Cohen GH, Moss B: Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge. J Virol 2005; 79:13454\u201313462.","journal-title":"J Virol"},{"key":"BF02685894_CR66","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1128\/AAC.49.7.2634-2641.2005","volume":"49","author":"JD Shearer","year":"2005","unstructured":"Shearer JD, Siemann L, Gerkovich M, House RV: Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection. Antimicrob Agents Chemother 2005; 49:2634\u20132641.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF02685894_CR67","first-page":"89","volume":"156","author":"EJ Wherry","year":"2001","unstructured":"Wherry EJ, Rajagopal D, Eisenlohr LC: Use of vaccinia virus expression vectors to investigate antigen processing and presentation. Methods Mol Biol 2001; 156:89\u2013109.","journal-title":"Methods Mol Biol"},{"key":"BF02685894_CR68","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","volume":"211","author":"IJ Amanna","year":"2006","unstructured":"Amanna IJ, Slifka MK, Crotty S: Immunity and immunological memory following smallpox vaccination. Immunol Rev 2006;211:320\u2013337.","journal-title":"Immunol Rev"},{"key":"BF02685894_CR69","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1084\/jem.145.3.644","volume":"145","author":"RM Zinkernagel","year":"1977","unstructured":"Zinkernagel RM, Althage A: Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 1977; 145:644\u2013651.","journal-title":"J Exp Med"},{"key":"BF02685894_CR70","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1128\/JVI.76.7.3329-3337.2002","volume":"76","author":"LE Harrington","year":"2002","unstructured":"Harrington LE, Most Rv R, Whitton JL, Ahmed R: Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J Virol 2002; 76:3329\u20133337.","journal-title":"J Virol"},{"key":"BF02685894_CR71","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1073\/pnas.89.13.6070","volume":"89","author":"MK Spriggs","year":"1992","unstructured":"Spriggs MK, Koller BH, Sato T, et al: Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinna virus and exhibit altered IgG responses. Proc Natl Acad Sci USA 1992; 89:6070\u20136074.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR72","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1073\/pnas.1233578100","volume":"100","author":"IM Belyakov","year":"2003","unstructured":"Belyakov IM, Earl P, Dzutsev A, et al: Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci USA 2003; 100:9458\u20139463.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR73","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20022222","volume":"197","author":"M Terajima","year":"2003","unstructured":"Terajima M, Cruz J, Raines G, et al: Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J Exp Med 2003; 197:927\u2013932.","journal-title":"J Exp Med"},{"key":"BF02685894_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1073\/pnas.262668999","volume":"100","author":"I Drexler","year":"2003","unstructured":"Drexler I, Staib C, Kastenmuller W, et al: Identification of vaccinia virus epitope-specific HLA-A*0201-testricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci USA 2003; 100:217\u2013222.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR75","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","volume":"78","author":"JT Snyder","year":"2004","unstructured":"Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA: Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J Virol 2004; 78:7052\u20137060.","journal-title":"J Virol"},{"key":"BF02685894_CR76","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.4049\/jimmunol.174.4.2212","volume":"174","author":"A Mathew","year":"2005","unstructured":"Mathew A, Terajima M, West K, et al: Indentification of murine poxvirus-specific CD8+CTL epitopes with distinct functional profiles. J Immunol 2005; 174:2212\u20132219.","journal-title":"J Immunol"},{"key":"BF02685894_CR77","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.175.8.5504","volume":"175","author":"V Pasquetto","year":"2005","unstructured":"Pasquetto V, Bui HH, Giannino R, et al: HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J Immunol 2005; 175:5504\u20135515.","journal-title":"J Immunol"},{"key":"BF02685894_CR78","doi-asserted-by":"publisher","first-page":"13980","DOI":"10.1073\/pnas.0506768102","volume":"102","author":"C Oseroff","year":"2005","unstructured":"Oseroff C, Kos F, Bui HH, et al: HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc Natl Acad Sci USA 2005; 102:13980\u201313985.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR79","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.humimm.2005.12.004","volume":"67","author":"M Terajima","year":"2006","unstructured":"Terajima M, Cruz J, Leporati AM, Demkowicz WE Jr, Kennedy JS, Ennis FA: Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. Hum Immunol 2006; 67:512\u2013520.","journal-title":"Hum Immunol"},{"key":"BF02685894_CR80","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature02240","volume":"427","author":"K Hanada","year":"2004","unstructured":"Hanada K, Yewdell JW, Yang JC: Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 2004; 427:252\u2013256.","journal-title":"Nature"},{"key":"BF02685894_CR81","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","volume":"153","author":"A Sette","year":"1994","unstructured":"Sette A, Vitiello A, Reherman B, et al: The relationship between class I binding affinity and immunologenicity of potential cytotoxic T cell cpotopes. J Immunol 1994; 153:5586\u20135592.","journal-title":"J Immunol"},{"key":"BF02685894_CR82","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.4049\/jimmunol.157.12.5555","volume":"157","author":"A Vitiello","year":"1996","unstructured":"Vitiello A, Yuan L, Chesnut RW, et al: Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J Immunol 1996; 157:5555\u20135562.","journal-title":"J Immunol"},{"key":"BF02685894_CR83","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.1128\/JVI.00427-06","volume":"80","author":"DC Tscharke","year":"2006","unstructured":"Tscharke DC, Woo WP, Sakala IG, et al: Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice. J Virol 2006; 80:6318\u20136323.","journal-title":"J Virol"},{"key":"BF02685894_CR84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998; 392:245\u2013252.","journal-title":"Nature"},{"key":"BF02685894_CR85","first-page":"175","volume":"27","author":"HJ Bontkes","year":"2005","unstructured":"Bontkes HJ, Ruizendaal JJ, Schreurs MW, Kramer D, Meijer CJ, Hooijberg E: Antigen gene transfer to human plasmacytoid dendritic cells using recombinant adenovirus and vaccinia virus vectors. Cell Oncol 2005; 27:175\u2013182.","journal-title":"Cell Oncol"},{"key":"BF02685894_CR86","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1074-7613(03)00051-7","volume":"18","author":"MF Princiotta","year":"2003","unstructured":"Princiotta MF, Finzi D, Qian SB, et al: Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003; 18:343\u2013354.","journal-title":"Immunity"},{"key":"BF02685894_CR87","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1073\/pnas.94.7.3183","volume":"94","author":"V Bronte","year":"1997","unstructured":"Bronte V, Carroll MW, Goletz TJ, et al: Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci USA 1997; 94:3183\u20133188.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR88","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.4049\/jimmunol.163.12.6762","volume":"163","author":"J Engelmayer","year":"1999","unstructured":"Engelmayer J, Larsson M, Subklewe M, et al: Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 1999; 163:6762\u20136768.","journal-title":"J Immunol"},{"key":"BF02685894_CR89","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1128\/JVI.75.5.2142-2153.2001","volume":"75","author":"J Engelmayer","year":"2001","unstructured":"Engelmayer J, Larsson M, Lee A, et al: Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals. J Virol 2001; 75:2142\u20132153.","journal-title":"J Virol"},{"key":"BF02685894_CR90","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1002\/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R","volume":"31","author":"M Larsson","year":"2001","unstructured":"Larsson M, Fonteneau JF, Somersan S, et al: Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur J Immunol 2001; 31:3432\u20133442.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF01317926","volume":"107","author":"Y Becker","year":"1989","unstructured":"Becker Y, Sprecher E: Langerhans cells in vaccinia virus infection in mouse skin. Arch Virol 1989; 107:307\u2013313.","journal-title":"Arch Virol"},{"key":"BF02685894_CR92","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.immuni.2006.03.014","volume":"24","author":"Y He","year":"2006","unstructured":"He Y, Zhang J, Donahue C, Falo LD Jr: Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant letivector-mediated genetic immunization. Immunity 2006; 24:643\u2013656.","journal-title":"Immunity"},{"key":"BF02685894_CR93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ni762","volume":"3","author":"CC Norbury","year":"2002","unstructured":"Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 2002; 3:265\u2013271.","journal-title":"Nat Immunol"},{"key":"BF02685894_CR94","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.172.4.1996","volume":"172","author":"GT Belz","year":"2004","unstructured":"Belz GT, Smith CM, Eichnet D, et al: Cutting edge: conventional CD8alpha(+) dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol 2004; 172:1996\u20132000.","journal-title":"J Immunol"},{"key":"BF02685894_CR95","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/357249a0","volume":"357","author":"A Lanzavecchia","year":"1992","unstructured":"Lanzavecchia A, Reid PA, Watts C. Irreversible association of peptides with class II MHC molecules in living cells. Nature 1992; 357:249\u2013252.","journal-title":"Nature"},{"key":"BF02685894_CR96","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<799::AID-IMMU799>3.0.CO;2-5","volume":"28","author":"VM Pinet","year":"1998","unstructured":"Pinet VM, Long EO: Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol 1998; 28:799\u2013804.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR97","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/j.1460-2075.1996.tb00372.x","volume":"15","author":"R Busch","year":"1996","unstructured":"Busch R, Cloutier I, Sekaly RP, Hammerling GJ: Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J 1996; 15:418\u2013428.","journal-title":"EMBO J"},{"key":"BF02685894_CR98","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/357702a0","volume":"357","author":"MS Malnati","year":"1992","unstructured":"Malnati MS, Marti M, LaVaute T, et al: Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 1992; 357:702\u2013704.","journal-title":"Nature"},{"key":"BF02685894_CR99","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.4049\/jimmunol.151.12.6751","volume":"151","author":"MS MaInati","year":"1993","unstructured":"MaInati MS, Ceman S, Weston M, DeMars R, and Long EO: Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J Immunol 1993; 151:6751\u20136756.","journal-title":"J Immunol"},{"key":"BF02685894_CR100","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/eji.1830251230","volume":"25","author":"A Oxenius","year":"1995","unstructured":"Oxenius A, Bachmann MF, Ashton-Rickardt PG, Tonegawa S, Zinkernagel RM, Hengarter H: Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur J Immunol 1995; 25:3402\u20133411.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR101","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.4049\/jimmunol.168.11.5403","volume":"168","author":"S Basta","year":"2002","unstructured":"Basta S, Chen W, Bennink JR, Yewdell JW: Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells. J Immunol 2002; 168:5403\u20135408.","journal-title":"J Immunol"},{"key":"BF02685894_CR102","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.169.8.4222","volume":"169","author":"X Shen","year":"2002","unstructured":"Shen X, Wong SB, Buck CB, Zhang J, Siliciano RF: Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes. J Immunol 2002; 169:4222\u20134229.","journal-title":"J Immunol"},{"key":"BF02685894_CR103","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.immunol.17.1.51","volume":"17","author":"JW Yewdell","year":"1999","unstructured":"Yewdell JW, Bennink JR: Immunodominance in major histocornpatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:51\u201388.","journal-title":"Annu Rev Immunol"},{"key":"BF02685894_CR104","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.4049\/jimmunol.175.12.8431","volume":"175","author":"CL Smith","year":"2005","unstructured":"Smith CL, Mirza F, Pasquetto V, et al: Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J Immunol 2005; 175:8431\u20138437.","journal-title":"J Immunol"},{"key":"BF02685894_CR105","first-page":"111","volume":"15","author":"GL Smith","year":"1999","unstructured":"Smith GL, Symons JA, Alcami A: Immune modulation by proteins secreted from cells infected by vaccinia virus. Arch Virol Suppl 1999; 15:111\u2013129.","journal-title":"Arch Virol Suppl"},{"key":"BF02685894_CR106","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1073\/pnas.0401165101","volume":"101","author":"LS Wyatt","year":"2004","unstructured":"Wyatt LS, Earl PL, Eller LA, Moss B: Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci USA 2004; 101:4590\u20134595.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR107","first-page":"195","volume":"84","author":"G Sutter","year":"1995","unstructured":"Sutter G, Moss B: Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus. Dev Biol Stand 1995; 84:195\u2013200.","journal-title":"Dev Biol Stand"},{"key":"BF02685894_CR108","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1099\/vir.0.80646-0","volume":"86","author":"C Staib","year":"2005","unstructured":"Staib C, Kisling S, Erfle V, Sutter G: Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J Gen Virol 2005; 86:1997\u20132006.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR109","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1099\/vir.0.81417-0","volume":"87","author":"RH Clark","year":"2006","unstructured":"Clark RH, Kenyon JC, Bartlett NW, Tscharke DC, Smith GL: Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol 2006; 87:29\u201338.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR110","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/eji.1830161203","volume":"16","author":"BE Coupar","year":"1986","unstructured":"Coupar BE, Andrew ME, Both GW, Boyle DB: Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur J Immunol 1986; 16:1479\u20131487.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR111","first-page":"5552","volume":"54","author":"JW Hodge","year":"1994","unstructured":"Hodge JW, Abrams S, Schlom J, Kantor, JA: Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res 1994; 54:5552\u20135555.","journal-title":"Cancer Res"},{"key":"BF02685894_CR112","first-page":"3598","volume":"55","author":"JW Hodge","year":"1995","unstructured":"Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA: Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res 1995; 55:3598\u20133603.","journal-title":"Cancer Res"},{"key":"BF02685894_CR113","first-page":"2832","volume":"56","author":"RS Chamberlain","year":"1996","unstructured":"Chamberlain RS, Carroll MW, Bronte V, et al: Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. Cancer Res 1996; 56:2832\u20132836.","journal-title":"Cancer Res"},{"key":"BF02685894_CR114","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1172\/JCI24624","volume":"115","author":"HL Kaufman","year":"2005","unstructured":"Kaufman HL, Deraffele G, Mitcham J, et al: Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J Clin Invest 2005; 115:1903\u20131912.","journal-title":"J Clin Invest"},{"key":"BF02685894_CR115","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0022-1759(96)00210-4","volume":"200","author":"WR Marti","year":"1997","unstructured":"Marti WR, Oertli D, Meko JB, Norton JA, Tsung K: Induction of antigen-presenting capacity in tumor cells upon infection with non-replicating recombinant vacinia virus encoding murine MHC class II and costimulatory molecules. J Immunol Methods 1997; 200:191\u2013198.","journal-title":"J Immunol Methods"},{"key":"BF02685894_CR116","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2249.1997.506-ce1405.x","volume":"110","author":"D Oertli","year":"1997","unstructured":"Oertli D, Marti WR, Norton JA, Tsung K: Artificial antigen-presenting cells engineered by recombinant vaccinia viruses expressing antigen, MHC class II, and costimulatory molecules elicit proliferation of CD4+ lymphocytes in vitro. Clin Exp Immunol 1997; 110:144\u2013149.","journal-title":"Clin Exp Immunol"},{"key":"BF02685894_CR117","first-page":"5800","volume":"59","author":"JW Hodge","year":"1999","unstructured":"Hodge JW, Sabzevari H, Yafal AG, Gritz L, Lorenz MG, Schlom J: A triad of costimulatory molecules synergize to amplify T-cell activation. Cancer Res 1999; 59:5800\u20135807.","journal-title":"Cancer Res"},{"key":"BF02685894_CR118","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1016\/S0264-410X(01)00062-7","volume":"19","author":"JW Hodge","year":"2001","unstructured":"Hodge JW, Grosenbach DW, Rad AN, Giuliano M, Sabzevari H, Schlorn J: Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules. Vaccine 2001; 19:3552\u20133567.","journal-title":"Vaccine"},{"key":"BF02685894_CR119","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/1078-0432.CCR-03-0145","volume":"10","author":"C Kudo-Saito","year":"2004","unstructured":"Kudo-Saito C, Schlom J, Hodge JW: Intratumoral vaccination and diversified subcutaneous\/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules. Clin Cancer Res 2004; 10:1090\u20131099.","journal-title":"Clin Cancer Res"},{"key":"BF02685894_CR120","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1200\/JCO.2005.10.206","volume":"23","author":"JL Marshall","year":"2005","unstructured":"Marshall JL, Gulley JL, Arlen PM, et al: Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol 2005; 23:720\u2013731.","journal-title":"J Clin Oncol"},{"key":"BF02685894_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-4-1","volume":"4","author":"R Dipaola","year":"2006","unstructured":"Dipaola R, Plante M, Kaufman H, et al: A phase I trial of pox PSA vaccines (PROSTVAC(R)-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM\u2122) in patients with prostate cancer. J Transl Med 2006; 4:1.","journal-title":"J Transl Med"},{"key":"BF02685894_CR122","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2174\/138161206775201929","volume":"12","author":"CT Garnett","year":"2006","unstructured":"Garnett CT, Greiner JW, Tsang KY, et al: TRICOM vector based cancer vaccines. Curr Pharm Des 2006; 12:351\u2013361.","journal-title":"Curr Pharm Des"},{"key":"BF02685894_CR123","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1016\/j.vaccine.2006.03.042","volume":"24","author":"C Kudo-Saito","year":"2006","unstructured":"Kudo-Saito C, Hodge JW, Kwak H, Kim-Schulze S, Schlom J, Kaufman HL: 4-1BB ligandenhances tumor-specific immunity of poxvirus vaccines. Vaccine 2006; 24:4975\u20134986.","journal-title":"Vaccine"},{"key":"BF02685894_CR124","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/10430349950018094","volume":"10","author":"MG Lorenz","year":"1999","unstructured":"Lorenz MG, Kantor JA, Schlom J, Hodge JW: Antitumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L). Hum Gene Ther 1999; 10:1095\u20131103.","journal-title":"Hum Gene Ther"},{"key":"BF02685894_CR125","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/329545a0","volume":"329","author":"IA Ramshaw","year":"1987","unstructured":"Ramshaw IA, Andrew ME, Phillips SM, Boyle DB, Coupar BE: Recovery of immunodeficient mice from a vaccinia virus\/IL-2 recombinant infection. Nature 1987; 329:545\u2013546.","journal-title":"Nature"},{"key":"BF02685894_CR126","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/330259a0","volume":"330","author":"C Flexner","year":"1987","unstructured":"Flexner C, Hugin A, Moss B: Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature 1987; 330:259\u2013262.","journal-title":"Nature"},{"key":"BF02685894_CR127","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.172.5.1495","volume":"172","author":"G Karupiah","year":"2007","unstructured":"Karupiah G, Blanden RV, Ramshaw IA: Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus\/interleukin 2 infection. J Exp Med 1990; 172:1495\u20131503.","journal-title":"J Exp Med"},{"key":"BF02685894_CR128","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/1043-4666(91)90028-C","volume":"3","author":"J Ruby","year":"1991","unstructured":"Ruby J, Fordham S, Kasprzak A, Osvath S, Ramshaw, I: The immunobiology of murine interleukin-1 alpha encoded by recombinant vaccinia virus. Cytokine 1991; 3:92\u201397.","journal-title":"Cytokine"},{"key":"BF02685894_CR129","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF02303631","volume":"2","author":"GR Peplinski","year":"1995","unstructured":"Peplinski GR, Tsung K, Whitman ED, Meko JB, Norton JA: Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta. Ann Surg Oncol 1995;2:151\u2013159.","journal-title":"Ann Surg Oncol"},{"key":"BF02685894_CR130","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1002\/eji.1830231215","volume":"23","author":"AJ Ramsay","year":"1993","unstructured":"Ramsay AJ, Kohonen-Corish M: Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur J Immunol 1993; 23:3141\u20133145.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR131","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1126\/science.8160012","volume":"264","author":"AJ Ramsay","year":"1994","unstructured":"Ramsay AJ, Husband AJ, Ramshaw IA, et al: The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994; 264:561\u2013563.","journal-title":"Science"},{"key":"BF02685894_CR132","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1128\/jvi.67.12.7623-7628.1993","volume":"67","author":"MG Kurilla","year":"1993","unstructured":"Kurilla MG, Swaminathan S, Welsh RM, Kieff E, Brutkiewicz RR: Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. J Virol 1993; 67:7623\u20137628.","journal-title":"J Virol"},{"key":"BF02685894_CR133","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0039-6060(96)80298-4","volume":"120","author":"JB Meko","year":"1996","unstructured":"Meko JB, Tsung K, Norton JA: Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12. Surgery 1996; 120:274\u2013282; discussion 282\u2013283.","journal-title":"Surgery"},{"key":"BF02685894_CR134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/viro.2002.1400","volume":"299","author":"AC Patera","year":"2002","unstructured":"Patera AC, Pesnicak L, Bertin J, Cohen, JI: Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 2002; 299:56\u201363.","journal-title":"Virology"},{"key":"BF02685894_CR135","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1089\/hum.1996.7.15-1853","volume":"7","author":"H Qin","year":"1996","unstructured":"Qin H, Chatterjee SK: Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF. Hum Gene Ther 1996; 7:1853\u20131860.","journal-title":"Hum Gene Ther"},{"key":"BF02685894_CR136","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1073\/pnas.88.9.4025","volume":"88","author":"SK Sambhi","year":"1991","unstructured":"Sambhi SK, Kohonen-Corish MR, Ramshaw IA: Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci USA 1991; 88:4025\u20134029.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02685894_CR137","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/1043-4666(92)90068-3","volume":"4","author":"ME Andrew","year":"1992","unstructured":"Andrew ME, Coupar BEH: Biological effects of recombinant vaccinia virus-expressed interleukin 4. Cytokine 1992; 4:281\u2013286.","journal-title":"Cytokine"},{"key":"BF02685894_CR138","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/jvi.70.10.7103-7107.1996","volume":"70","author":"DP Sharma","year":"1996","unstructured":"Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA: Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 1996; 70:7103\u20137107.","journal-title":"J Virol"},{"key":"BF02685894_CR139","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","volume":"86","author":"DJ Esteban","year":"2005","unstructured":"Esteban DJ, Buller RM: Ectromelia virus: the causative agent of mousepox. J Gen Virol 2005; 86:2645\u20132659.","journal-title":"J Gen Virol"},{"key":"BF02685894_CR140","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1128\/jvi.70.12.8301-8309.1996","volume":"70","author":"G Karupiah","year":"1996","unstructured":"Karupiah G, Buller RM, Van Rooijen N, Duarte CJ, Chen J: Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 1996; 70:8301\u20138309.","journal-title":"J Virol"},{"key":"BF02685894_CR141","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","volume":"75","author":"RJ Jackson","year":"2001","unstructured":"Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA: Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 2001; 75:1205\u20131210.","journal-title":"J Virol"},{"key":"BF02685894_CR142","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1128\/JVI.75.18.8353-8355.2001","volume":"75","author":"A Mullbacher","year":"2001","unstructured":"Mullbacher A, Lobigs M: Cration of killer poxvirus could have been predicted. J Virol 2001; 75:8353\u20138355.","journal-title":"J Virol"},{"key":"BF02685894_CR143","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.164.7.3487","volume":"164","author":"S Aung","year":"2000","unstructured":"Aung S, Graham BS: IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo. J Immunol 2000; 164:3487\u20133493.","journal-title":"J Immunol"},{"key":"BF02685894_CR144","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/eji.1830251209","volume":"25","author":"D Kagi","year":"1995","unstructured":"Kagi D, Seiler P, Pavlovic J, et al: The roles of perforinand Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995; 25:3256\u20133262.","journal-title":"Eur J Immunol"},{"key":"BF02685894_CR145","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.73.2.1665-1667.1999","volume":"73","author":"A Mullbacher","year":"1999","unstructured":"Mullbacher A, Hla RT, Museteanu C, Simon MM: Perforin is essential for control of ectromelia virus but not related poxviruses in mice. J Virol 1999; 73:1665\u20131667.","journal-title":"J Virol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02685894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02685894\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02685894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02685894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:37:06Z","timestamp":1684859826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02685894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":145,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF02685894"],"URL":"https:\/\/doi.org\/10.1007\/bf02685894","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}